Skip to main content

Table 2 Change in blood pressure and TC/HDL among SA-CHAMP participants who completed follow-up

From: Feasibility of community-based screening for cardiovascular disease risk in an ethnic community: the South Asian Cardiovascular Health Assessment and Management Program (SA-CHAMP)

Characteristic n Baseline proportion Follow-up proportion Mean difference (95% C.I.) p-value
Elevated systolic and/or diastolic blood pressure *      
  All 99 0.39 0.35 −0.04 (−0.14 to 0.06) 0.524
  Men 52 0.38 0.33 −0.06 (−0.21 to 0.10) 0.581
  Women 47 0.40 0.38 −0.02 (−0.17 to 0.12) 1.000
  Diabetics 27 0.52 0.56 0.04 (−0.22 to 0.30) 0.739
  Non-diabetics 72 0.35 0.28 −0.07 (−0.18 to 0.04) 0.267
Controlled TC/HDL§      
  All 98 0.34 0.46 0.12 (0.01 to 0.23) 0.029
  Men 51 0.20 0.37 0.18 (0.03 to 0.33) 0.023
  Women 47 0.49 0.55 0.06 (−0.10 to 0.23) 0.581
  Diabetics 27 0.30 0.37 0.07 (−0.14 to 0.29) 0.688
  Non-Diabetics 71 0.35 0.49 0.14 (0.01 to 0.27) 0.041
  n Mean at baseline Mean at follow-up Mean paired difference (95% C.I.) p-value
Total Cholesterol      
  All 99 5.56 5.04 −0.52 (−0.71 to −0.34) < 0.001
  Men 52 5.34 4.81 −0.53 (−0.81 to −0.24) < 0.001
  Women 47 5.81 5.30 −0.52 (−0.76 to −0.28) <0.001
  Diabetics 27 5.45 5.13 −0.32 (−0.63 to −0.01) 0.043
  Non-Diabetics 72 5.61 5.01 −0.60 (−0.83 to −0.37) <0.001
HDL Cholesterol      
  All 98 1.08 1.15 0.07 (0.03 to 0.11) 0.002
  Men 51 0.96 1.03 0.06 (0.00 to 0.12) 0.038
  Women 47 1.21 1.29 0.08 (0.01 to 0.14) 0.029
  Diabetics 27 1.08 1.11 0.04 (0.06 to 0.13) 0.456
  Non-Diabetics 71 1.09 1.17 0.08 (0.03 to 0.13) 0.002
TC/HDL      
  All 98 5.80 4.76 −1.04 (−1.41 to −0.68) <0.001
  Men 51 6.34 5.03 −1.31 (−1.92 to −0.69) <0.001
  Women 47 5.21 4.46 −0.76 (−1.13 to −0.38) <0.001
  Diabetics 27 5.85 4.98 −0.87 (−1.70 to −0.04) 0.041
  Non-Diabetics 71 5.78 4.67 −1.11 (−1.51 to −0.71) <0.001
  1. * Elevated systolic blood pressure: > = 140 mm Hg (non-diabetics) or > = 130 mm Hg (diabetics); elevated diastolic blood pressure: > = 90 mm Hg (non-diabetics) or > = 80 mm Hg (diabetics).
  2. § Controlled TC/HDL: < 4 for high risk participants; < 6 for low-moderate risk participants.